Zobrazeno 1 - 10
of 6 031
pro vyhledávání: ''
Autor:
TAKEHIRO OTOSHI, TATSUYA NAGANO, JONGUK PARK, KOJI HOSOMI, TOMOYA YAMASHITA, MOTOKO TACHIHARA, TOKIKO TABATA, REINA SEKIYA, YUGO TANAKA, KAZUYUKI KOBAYASHI, KENJI MIZUGUCHI, TOMOO ITOH, YOSHIMASA MANIWA, JUN KUNISAWA, YOSHIHIRO NISHIMURA
Publikováno v:
Anticancer Research. 42:1589-1598
The gut microbiome plays an important role in the immune system and has attracted attention as a biomarker of several diseases, including cancer. In this study, we examined the relationship between the gut microbiome and lung cancer progression.Femal
Autor:
Kiki C. Andree, Menno Tamminga, Harry J.M. Groen, T. Jeroen N. Hiltermann, Ed Schuuring, Leon W.M.M. Terstappen, Anouk Mentink, Hilda van den Bos, Peter M. Lansdorp, Wim Timens, Diana C.J. Spierings
Publikováno v:
British journal of cancer, 126, 409-418. Nature Publishing Group
Br J Cancer
British Journal of Cancer, 126. Nature Publishing Group
Br J Cancer
British Journal of Cancer, 126. Nature Publishing Group
BACKGROUND: Circulating tumour cells (CTCs) can be used to monitor cancer longitudinally, but their use in non-small cell lung cancer (NSCLC) is limited due to low numbers in the peripheral blood. Through diagnostic leukapheresis (DLA) CTCs can be ob
Publikováno v:
Future Oncology. 18:679-690
Objective: D-dimer is correlated to the poor prognosis of non-small-cell lung cancer. The study aimed to investigate the association between plasma D-dimer and concomitant mutations in non-small-cell lung cancer. Methods: A total of 517 non-small-cel
Autor:
Tomoko Yoshida, Kazuhiko Takeda, Toshihiko Kaneda, Hiroaki Yanagimoto, Takao Yoshida, Kayoko Kibata, Koji Tsuta, Takayasu Kurata, Hiroshige Yoshioka
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Background Immune checkpoint inhibitors prolong the survival of non-small cell lung cancer (NSCLC) patients. Although it has been acknowledged that there is some correlation between the efficacy of anti-programmed cell death-1 (PD-1) antibody therapy
Autor:
Jitsuo Usuda, Susumu Takeuchi, Kengo Nagashima, Noriko Motoi, Masahiro Seike, Jun Matsubayashi, Hideaki Shiraishi, Kazufumi Honda, Shun-ichi Watanabe, Rintaro Noro, Kaoru Kubota, Xue Meng, Tatsuya Inoue, Huang Wilber, Ayumi Kashiro, Tetsuya Okano, Yukihiro Yoshida, Shinobu Kunugi, Akihiko Gemma, Norihiko Ikeda
Publikováno v:
Cancer Science. 113:1002-1009
Although adjuvant tegafur/uracil (UFT) is recommended for patients with completely resected stage I non-small cell lung cancer (NSCLC) in Japan, only one-third of cases has received adjuvant chemotherapy according to real-world data. Therefore, robus
Autor:
BADIU, DUMITRU CRISTINEL, ZGURA, ANCA, MEHEDINTU, CLAUDIA, HAINEALA, BOGDAN, ANGHEL, RODICA, BACINSCHI, XENIA
Publikováno v:
In Vivo
Background/Aim: Lung cancer is the most common cancer worldwide. Cancer immunotherapy is the activation of the immune system against cancer. The latest method of immunotherapy involves immune checkpoint inhibitors. Increased levels of programmed deat
Autor:
Jacques Remy, Marie-Christine Copin, Alain Duhamel, Alexis B. Cortot, Julie Dewaguet, Eric Wasielewski, Valérie Deken, Thomas Flohr, Martin Sedlmair, Bernhard Schmidt, Martine Remy-Jardin, Jean-Baptiste Faivre
Publikováno v:
Radiology. 302:448-456
Background Active endothelial cell proliferation occurs at the tumor edge, known as the invading-tumor front. This study focused on perfusion analysis of non-small cell lung cancers. Purpose To analyze dual-phase, dual-energy CT perfusion according t
Autor:
Josephine Feliciano, Michael Lim, Pavan P. Shah, Jarushka Naidoo, Christopher M. Jackson, Kristen A. Marrone, Lawrence Kleinberg, Siddhartha Srivastava, Julie R. Brahmer, John Choi, Patrick M. Forde, Kristin J. Redmond, Jennifer L. Franke, David S. Ettinger, Benjamin Levy, Ravi Medikonda
Publikováno v:
Journal of Neurosurgery. 136:56-66
OBJECTIVE Non–small cell lung cancer (NSCLC) is the most common primary tumor to develop brain metastasis. Prognostic markers are needed to better determine survival after neurosurgical resection of intracranial disease. Given the importance of mut
Autor:
Hye Jin Jang, Ji Yeon Choi, Kangjoon Kim, Seung Hyun Yong, Yeon Wook Kim, Song Yee Kim, Eun Young Kim, Ji Ye Jung, Young Ae Kang, Moo Suk Park, Young Sam Kim, Young-Jae Cho, Sang Hoon Lee
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-10 (2021)
Respiratory Research
Respiratory Research
Background Lung cancer is the primary cause of cancer-related deaths worldwide. The human lung serves as a niche to a unique and dynamic bacterial community that is related to the development of multiple diseases. Here, we investigated the difference
Autor:
Jennifer King, Upal Basu Roy, M. Patricia Rivera, Bruce E. Johnson, Adam H. Fox, James R. Jett, Nikki A. Martin, Raymond U. Osarogiagbon, Lauren S. Rosenthal, Gerard A. Silvestri, Robert A. Smith
Publikováno v:
Chest
BACKGROUND: Targeted therapies for advanced non-small cell lung cancer (NSCLC) with oncogenic drivers have caused a paradigm shift in care. Biomarker testing is needed to assess eligibility for these therapies. Pulmonologists often perform bronchosco